Sun Pharmaceutical Industries Limited CC-Mar24.pdf ·
My first question is on your comment that you would be in investment phase during the next financial year. So just wanted to understand, would this be more skewed towards R&D? Or would it be more For further updates and specific queries, please visit www.sunpharma.com or feel free to contact Abhishek Sharma, +91 22 43242929, abhi.sharma@sunpharma.com, Gaurav Chugh, +91 22 43245373, gaurav.chugh@sunpharma.com, evenly set between the R&D and launch expenses related to your specialty products in the U.S.? I mean, how should we think about this?
Yes. That helps. And the second question is related to your tax rate. I mean how should we think about it on an annual basis over the next few years?